Gossamer Bio is a San Diego biopharmaceutical company developing seralutinib, an inhaled drug for pulmonary hypertension. It last closed at $11.21 on Nov 17, up 2.09% on the day. The average 12-month price target from 4 analysts is $94.50 (+743.0% from the last close), with a high of $160.00 and a low of $32.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell).
Each firm's latest rating on GOSS in the past 90 days
Average 12-month target
$94.50
▲ 743.0% upside
Based on 4 analysts who set a price target on GOSS in the past 90 days. The average target is $94.50, with a high of $160.00 and a low of $32.00, compared with the last close of $11.21.
Low $32.00Avg $94.50High $160.00
Blue marker: last close $11.21
Highest target$160.00
Average target$94.50
Lowest target$32.00
Latest rating changes
Piper SandlerTarget raised
Nov 11Buy$4 → $96
WedbushMaintained
Nov 11Hold$32
Chardan CapitalMaintained
Oct 15Buy$160
Chardan CapitalInitiated
Oct 13Buy$160
HC Wainwright & Co.Target raised
Sep 21Buy$2 → $90
Date
Firm
Action
Rating
Price target
Nov 11
Piper Sandler
Target raised
Buy
$4 → $96
Nov 11
Wedbush
Maintained
Hold
$32
Oct 15
Chardan Capital
Maintained
Buy
$160
Oct 13
Chardan Capital
Initiated
Buy
$160
Sep 21
HC Wainwright & Co.
Target raised
Buy
$2 → $90
Loading…
Technical Analysis
GOSS · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend
The stock is 8% above its 20 day and 7% above its 50 day average. It is 163% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 56). The nearest support is the swing low (Jun 10) at $11.20, and the nearest resistance the Pivot R1 at $11.70.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityNormal, 9.4%/day
Key levels
$309.6052 week high+2661.8%
$29.44200 day average+162.6%
$12.15Swing high (Nov 12)+8.4%
$11.99100 day average+7.0%
$11.70Pivot R1+4.4%
$11.21Last close
$11.20Swing low (Jun 10)−0.1%
$10.96Pivot−2.2%
$10.47Pivot S1−6.6%
$10.4450 day average−6.9%
$10.2920 day average−8.2%
$8.2952 week low−26.0%
Indicators
RSI (14)
56.36
Middle of its range
Neutral
MACD
0.25
Above its signal line
Bullish
Stochastic
70.2
Middle of its range
Neutral
ADX (14)
10.5
No clear trend
Williams %R
-28.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
75.6
Oversold below −100, overbought above 100
Neutral
Rate of change
+20.8%
Change over 10 sessions
Bullish
ATR (14)
$1.05
Typical daily range, 9.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 49.2%/day
Key levels
$309.6052 week high+2661.8%
$29.44200 day average+162.6%
$12.15Swing high (Nov 12)+8.4%
$11.99100 day average+7.0%
$11.70Pivot R1+4.4%
$11.21Last close
$11.20Swing low (Jun 10)−0.1%
$10.96Pivot−2.2%
$10.47Pivot S1−6.6%
$10.4450 day average−6.9%
$10.2920 day average−8.2%
$8.2952 week low−26.0%
Indicators
RSI (14)
32.07
Weak, oversold below 30
Neutral
MACD
-11.00
Above its signal line
Bullish
Stochastic
27.9
Middle of its range
Neutral
ADX (14)
33.4
Trending down
Williams %R
-66.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-38.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+4.5%
Change over 10 sessions
Bullish
ATR (14)
$5.51
Typical daily range, 49.2% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GOSS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GOSS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow GOSS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How GOSS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GOSS is in one of them and how their past GOSS trades turned out.
Gossamer Bio is a biopharmaceutical company based in San Diego, California. It is developing seralutinib, an investigational inhaled medicine for pulmonary arterial hypertension and for pulmonary hypertension linked to interstitial lung disease. The drug is still in clinical trials and is not yet approved for sale. The company works with Chiesi on development and potential commercialization, and it focuses on people living with pulmonary hypertension.